The innovative medicines initiative: a European response to the innovation challenge.

نویسنده

  • M Goldman
چکیده

The Innovative Medicines Initiative (IMI) was launched in 2008 as a large-scale public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). With a total budget of €2 billion, the IMI aims to boost the development of new medicines across Europe by implementing new collaborative endeavors between large pharmaceutical companies and other key actors in the health-care ecosystem, i.e., academic institutions, small and medium enterprises, patients, and regulatory authorities. Projects conducted by IMI consortia have already delivered meaningful results, providing proof-of-concept evidence for the efficiency of this new model of collaboration. In this article we review recent achievements of the IMI consortia and discuss the growing interest in the IMI as a best-practice model to reinvigorate drug development.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Eco-innovation: the profile of Poland in comparison to the European Union

Innovativeness, determining the development potential of enterprises and economies, and hence the economic welfare of societies, became an important area of interest for both theoreticians and especially economic life practitioners. Thus, in this study of the subject there can be found numerous definitions and types of innovation, including environmental innovation, being a response to the dema...

متن کامل

Public-private partnerships as driving forces in the quest for innovative medicines

UNLABELLED BACKGROUND Despite progress in translational research, we are still falling short in developing the innovative medicines required to address major public health needs. Furthermore, the failure rate, time, and cost required for registration of a new drug are pushing the economics of the industry to the breaking point. New models of drug development based on collaborative endeavours...

متن کامل

The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.

T he introduction of truly new drug treatments is dwindling to a troublesome extent in all fields of medicine, at the same time as the costs for drug development are skyrocketing. New strategies are urgently required as old schemes for drug development are failing. The largest European public–private partnership in biomedical research, the Innovative Medicines Initiative (IMI), is therefore lau...

متن کامل

The Role of Innovative Entrepreneurship in Economic Development: A Study of G20 Countries

Innovation and entrepreneurship are considered key factors of growth and survival of modern economies. According to Schumpeter (1934), “carrying out innovations is the only function which is fundamental in history". The review of recent studies reveals that high levels of newly growing up innovative firms are strongly related to economic growth (Stam, 2008).The vinculum of innovation, entrepren...

متن کامل

Identifying Green Banking Components Based on Innovation Management to Achieve Sustainable Competitive Advantage

Background: The banking industry can create sustainable development and be a competitive advantage of the enterprise by promoting a sustainable environment and investment focused on social responsibility. Therefore, the present study was formed with the aim of identifying the components of innovative green banking based on bioethics. Method: The research method in the present study was qualita...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Clinical pharmacology and therapeutics

دوره 91 3  شماره 

صفحات  -

تاریخ انتشار 2012